# What can research say about orthobiologics, the blood- or tissue-based shots? *Does the Research Fit You? | Orthobiologics Glendale* > Orthobiologics Glendale research in useful terms: whether a report matches your joint, your soreness, and the care being discussed. We’ll help you judge whether a report has much to do with your joint and with orthobiologics, office shots that may use blood or tissue from your pelvis, body fat, or a donor. A report about one kind can’t answer for all the others. ## Does the research match my joint? A report about knee soreness can’t settle questions about a shoulder or hip. A study of mild wear may say little about a badly worn joint. You can ask whether the people had the same joint and similar wear. That answer isn’t a small detail. Feeling better after a procedure doesn’t always prove that the procedure caused the change itself, because rest, easy exercise, or simple time may also ease soreness during a study. Some people improve after a visit because they reduce a painful motion. A useful report compares the new procedure with those other reasons for relief. One plain question can uncover that difference. ## Does PRP work after my blood is spun and its platelets are kept? PRP means platelet-rich plasma, the smaller portion kept when a machine spins your drawn blood. Reports about PRP can’t answer every joint in the same way. Some find relief, while other careful reports find little change. The platelet amount may also vary by office. You can ask how much better people felt and how long that change lasted. It’s also worth asking what other care they received during the study. Clear limits help you weigh the cost and recovery against the chance of continued soreness. You needn’t translate a broad claim by yourself. ## What if I still want the joint examined? When soreness continues, you can ask QC Kinetix for a joint exam followed by a talk about other care. A medical provider means the licensed clinician who sees you there. That person can explain regenerative treatments, which place blood or body tissue into the sore joint or tendon with a needle. PRP and concentrated PRP may be discussed afterward. You’re invited to ask which report studied the same procedure now being discussed. The provider can explain recovery, later checks, and what happens without improvement. Waiting without a new procedure may also be part of the talk. A clear answer stays close to your joint. ## Sources 1. A Bayesian network meta-analysis of 48 Level I-II randomized trials (9,338 knees) with a minimum 6-month follow-up ranked the four commonest intra-articular injections. HA and PRP both significantly improved pain versus placebo; HA, PRP and BMAC all significantly improved function versus placebo. SUCRA rankings were PRP 91.54, BMAC 76.46, HA 53.12, corticosteroid 15.18 and placebo 13.70 - corticosteroid ranked barely above placebo at six months and beyond. Jawanda H, et al. — [Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/38331363/). *Arthroscopy*, 2024. DOI: 10.1016/j.arthro.2024.01.037. 2. A network meta-analysis restricted to LARGE randomized trials (at least 100 patients per group; 57 RCTs, 22,795 participants, 18 intra-articular interventions) found treatment effects were consistently larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials. In the main analysis excluding high-risk trials, triamcinolone had the highest probability of exceeding the minimal important difference at weeks 2 and 6; hyaluronic acid had no effect on pain (SMD -0.04, 95% CrI -0.19 to 0.11, 11 trials) but higher odds of dropouts due to adverse events (OR 2.01) and of serious adverse events (OR 1.86). The effects of 16 of the 18 interventions were smaller than the MID and most were consistent with placebo effects. Pereira TV, et al. — [Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/39265924/). *Osteoarthritis and Cartilage*, 2025. DOI: 10.1016/j.joca.2024.08.014. 3. RESTORE, the largest and most rigorously blinded placebo-controlled PRP trial in knee OA (n=288, participant-, injector- and assessor-blinded), gave three weekly injections of a commercial leukocyte-poor PRP or saline. At 12 months the change in knee pain was -2.1 vs -1.8 points (difference -0.4; 95% CI -0.9 to 0.2; P=.17) and the change in medial tibial cartilage volume was -1.4% vs -1.2% (difference -0.2%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no between-group difference. The authors concluded the findings do not support the use of PRP for knee OA. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 4. The largest head-to-head trial of cell-based orthobiologics to date randomised 480 patients with KL II-IV knee OA across four arms: autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, allogeneic umbilical cord tissue-derived MSCs, and a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another or to the corticosteroid control on either co-primary endpoint (VAS pain, KOOS pain), and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events were reported. Mautner K, et al. — [Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.](https://pubmed.ncbi.nlm.nih.gov/37919438/). *Nature Medicine*, 2023. DOI: 10.1038/s41591-023-02632-w. 5. The 2025 Cochrane review of stem cell injections for knee osteoarthritis pooled 25 randomised trials (1,341 participants) and found that, compared with placebo injection, stem cell injection MAY slightly improve pain (1.2 points better on a 0-10 scale, 7 studies, 445 participants) and function (14.2 points better on a 0-100 scale, 7 studies, 432 participants) up to six months - both rated LOW-certainty evidence, downgraded for indirectness (cell source, preparation and dose varied across studies) and suspected publication bias, since up to three larger RCTs were conducted and withdrawn before reporting results. Radiographic progression was not assessed in any included study. Whittle SL, et al. — [Stem cell injections for osteoarthritis of the knee.](https://pubmed.ncbi.nlm.nih.gov/40169165/). *Cochrane Database of Systematic Reviews*, 2025. DOI: 10.1002/14651858.CD013342.pub2. 6. The ESSKA-ORBIT European consensus on blood-derived orthobiologics graded 28 question-statement sets; only 9 of 28 had high-level scientific support. Three statements reached grade A: that there is enough preclinical and clinical evidence to support PRP use in knee OA; that clinical evidence shows effectiveness in MILD TO MODERATE knee OA (KL grade 3 or lower); and that PRP provides a longer effect than the short-term effect of corticosteroid with a safer profile. The panel regarded PRP as a valid and possible first-line injectable option for KL grades 1-3. Laver L, et al. — [The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma).](https://pubmed.ncbi.nlm.nih.gov/38436492/). *Knee Surgery, Sports Traumatology, Arthroscopy*, 2024. DOI: 10.1002/ksa.12077. 7. A meta-analysis of the PLACEBO arms of 73 double-blind trials (5,895 patients) quantified what a saline knee injection alone achieves: statistically and clinically significant improvement in pain, function and quality of life at 1, 3 and 6 months, with responder rates exceeding 50% at all three time points, peaking around 4-8 months and declining by 12 months. Placebo response was stronger in trials with more female participants and in more recently published trials. Previtali D, et al. — [Placebo response to intra-articular injections in knee osteoarthritis: magnitude, evolution over time, and influencing factors. A systematic review and meta-analysis with meta-regression.](https://pubmed.ncbi.nlm.nih.gov/41031623/). *EFORT Open Reviews*, 2025. DOI: 10.1530/EOR-2025-0022. 8. A meta-analysis of 24 RCTs (1,653 participants) with plantar fasciitis found PRP produced significantly better VAS pain than corticosteroid at 3 and 6 months but not at 1 month or 12 months, and better AOFAS function scores at 3, 6 and 12 months. Plantar fascia thickness did not differ significantly at any time point. Zuo A, et al. — [Platelet-Rich Plasma Versus Corticosteroids in the Treatment of Plantar Fasciitis: A Systematic Review and Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/39778212/). *American Journal of Physical Medicine & Rehabilitation*, 2025. DOI: 10.1097/PHM.0000000000002677. ## What if your joint is still sore? At its Phoenix-area offices, QC Kinetix has visits for people whose joints remain sore. A licensed clinician, called a medical provider here, discusses regenerative treatments after the exam. These office procedures use a needle to place material from blood or body tissue into the sore area. The Peoria office serves the Loop 101 side of Glendale, while Banner Estrella may suit Westgate and the south side. You can call with questions about the exam, price, recovery, and later care. One number reaches both offices: (602) 837-PAIN. You’re welcome to take time before deciding. Nothing needs to be rushed. Book an appointment: --- A comfortable place to begin when a joint keeps aching. A Glendale guide to aching joints, simple comfort measures, reasons for urgent care, office visits, and choices that avoid an operation. Clear help for sore joints, simple care at home, urgent signs, and nearby visits. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Peoria and Banner Estrella locations described here, and those owners benefit when readers book with their clinics. © 2026 Glendale Orthobiologics Guide. General health education and local access context, not personal medical advice or a diagnosis.